Previous investigations have demonstrated that besides the intestine at least 20 tissues including brain all have receptors for 1,25dihydroxyvitamin D3 (1,25(OH)2D3) and/or a vitamin D induced calcium binding protein (CaBP), thus suggesting a wider role for vitamin D in calcium metabolism than mere intestinal calcium absorption. The object of this proposal is to obtain a better understanding of the role of the calcium homeostat steroid hormone, 1,25(OH)2D3 in specific brain function and in the control of epileptogenic activity. Specifically we will study the effect of alterations in the vitamin D endocrine system on seizure activity and threshold. Brain regions functionally activated by 1,25(OH)2D3 administration will be analyzed by (14C) 2-deoxyglucose (2DG). In a related study we will examine how 1,25(OH)2D3 administration might alter the spread of epileptiform activity as determined by 2DG autoradiography. The effect of 1,25(OH)2D3 on activities of monamine oxidase and choline acetylase in specific brain nuclei will be determined. In an effort to determine the functional significance of the vitamine D dependent calcium binding protein (CaBP) in brain, the ability of CaBP to stimulate synaptic vesicle neurotransmitter release and protein phosphorylation will be examined. The interaction of CaBP with cellular and particulate constituents of various brain regions will be investigated and the brain proteins bound to CaBP and those bound to calmodulin will be compared using an SDS gel overlay technique. Finally, previous studies concerning alterations in brain CaBP with kindling induced seizures will be extended. We will determine molecular mechanisms involved in an alteration in CaBP and whether other proteins or gene products are affected by kindling induced seizures in specific brain regions. It is likely that important advances to the understanding of epilepsy can be made by examining molecular level changes and that molecular genetics will play an increasingly important role in the elucidation of the mechanism of control of the epileptic state.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Project (R01)
Project #
5R01NS020270-02
Application #
3400559
Study Section
Neurology A Study Section (NEUA)
Project Start
1983-12-01
Project End
1986-11-30
Budget Start
1984-12-01
Budget End
1985-11-30
Support Year
2
Fiscal Year
1985
Total Cost
Indirect Cost
Name
University of Medicine & Dentistry of NJ
Department
Type
Schools of Medicine
DUNS #
605799469
City
Newark
State
NJ
Country
United States
Zip Code
Wang, Y Z; Christakos, S (1995) Retinoic acid regulates the expression of the calcium binding protein, calbindin-D28K. Mol Endocrinol 9:1510-21
Lee, S; Miskovsky, J; Williamson, J et al. (1994) Changes in glutamate receptor and proenkephalin gene expression after kindled seizures. Brain Res Mol Brain Res 24:34-42
Cheng, B; Christakos, S; Mattson, M P (1994) Tumor necrosis factors protect neurons against metabolic-excitotoxic insults and promote maintenance of calcium homeostasis. Neuron 12:139-53
Lee, S; Christakos, S; Small, M B (1993) Apoptosis and signal transduction: clues to a molecular mechanism. Curr Opin Cell Biol 5:286-91
Katsetos, C D; Frankfurter, A; Christakos, S et al. (1993) Differential localization of class III, beta-tubulin isotype and calbindin-D28k defines distinct neuronal types in the developing human cerebellar cortex. J Neuropathol Exp Neurol 52:655-66
Walters, M R; Fischette, C T; Fetzer, C et al. (1992) Specific 1,25-dihydroxyvitamin D3 binding sites in choroid plexus. Eur J Pharmacol 213:309-11
Reisner, P D; Christakos, S; Vanaman, T C (1992) In vitro enzyme activation with calbindin-D28k, the vitamin D-dependent 28 kDa calcium binding protein. FEBS Lett 297:127-31
Iacopino, A M; Christakos, S; Modi, P et al. (1992) Nerve growth factor increases calcium binding protein (calbindin-D28K) in rat olfactory bulb. Brain Res 578:305-10
Iacopino, A; Christakos, S; German, D et al. (1992) Calbindin-D28K-containing neurons in animal models of neurodegeneration: possible protection from excitotoxicity. Brain Res Mol Brain Res 13:251-61
Sonnenberg, J L; Frantz, G D; Lee, S et al. (1991) Calcium binding protein (calbindin-D28k) and glutamate decarboxylase gene expression after kindling induced seizures. Brain Res Mol Brain Res 9:179-90

Showing the most recent 10 out of 32 publications